LAB vs CBLL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

LAB

56.3
AI Score
VS
LAB Wins

CBLL

47.4
AI Score

Investment Advisor Scores

LAB

56score
Recommendation
HOLD

CBLL

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric LAB CBLL Winner
Revenue 41.25M 54.59M CBLL
Net Income 100.31M -39.01M LAB
Gross Margin 53.0% 89.9% CBLL
Net Margin 243.2% -71.4% LAB
Operating Income -37.88M -40.73M LAB
ROE 18.6% -30.4% LAB
ROA 16.0% -23.4% LAB
Total Assets 627.22M 166.35M LAB
Cash 270.03M 32.66M LAB
Current Ratio 9.10 9.18 CBLL
Free Cash Flow -57.82M -32.30M CBLL

Relative Price Performance (Last 90 Days)

LAB 1M: -13.1% · 3M: -23.9% CBLL 1M: +3.1% · 3M: +30.2%

Current Technical Phase

LAB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.4%), weak momentum, RSI 45

RSI (14): 44.5 · Price: $0.69

CBLL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.7% over 20 days), RSI 56

RSI (14): 56.0 · Price: $23.63

Fundamentals Snapshot

Metric LAB CBLL
Market Cap
Forward P/E -4.3 -14.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.3%
Gross Margin 0.5% 0.9%
Operating Margin -0.4% -0.7%
EPS -0.13 -1.69
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, LAB is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.